Measles: Difference between revisions

Line 22: Line 22:


[[File:Koplik's Spots on Cheek.jpg]]
[[File:Koplik's Spots on Cheek.jpg]]
[[File:Koplik's Spots on Palate.jpg]]
[[File:Measle's Rash on Face.jpg]]
[[File:Measle's Rash on on Thorax.jpg]]


==Work Up==
==Work Up==

Revision as of 02:05, 26 February 2014

Background

  • 10d incubation period
  • 3d prodromal period

Current Outbreaks

  • 2/14
    • 14 known measles cases in California
    • 5 of the patients recently traveled to the Philippines or had contact with international travelers
    • the majority of patients were unvaccinated
    • a recent outbreak in the Philippines has resulted in over 20 deaths and thousands of cases

Diagnosis

  • Begins with URI symptoms: high fever, cough, coryza, and conjunctivitis
  • Koplik's spots (appears day 2-3)
    • Pathognomonic enanthem
    • Tiny red spots (base) with bluish-white centers on the mucosa of the cheek or palate
  • Rash (begins day 4 - lasts to day 7)
    • red, blotchy, and maculopapular; rapidly progresses to confluence
    • Usually starts on the face (hairline and behind the ears)
    • Rapidly spreads to the chest, back, and finally the legs and feet
  • Obtain a history of measles immunization, travel outside of the Americas, or contact with international travelers in recent weeks. Simple community transmission is also possible.

Koplik's Spots on Cheek.jpg Koplik's Spots on Palate.jpg Measle's Rash on Face.jpg Measle's Rash on on Thorax.jpg

Work Up

  • Usually you need (check with your lab):
    • 1-2 ml blood in a red-top tube
    • throat or nasopharyngeal swab using a viral culturette with viral transport media
    • 10-40 ml of urine in a sterile container.

Management

  • Alert local health department ASAP
    • The risk of measles transmission to others and large contact investigations can be reduced if control measures are implemented immediately.

Post-Exposure Prophylaxis

  • Can be administered to contacts
  • Checking with your local health authorities
    • Within 72 hours of exposure use MMR vaccine
    • Up to 6 days after exposure use IM immune globulin

Infectious Precautions

  • For suspected patients
    • MASK the patient and ISOLATE immediately in an airborne infection isolation room
    • All personnel entering the room should use respiratory protection at least as effective as an N95 respirator
    • If possible, allow only personnel with documentation of 2 doses of live measles vaccine or laboratory evidence of immunity (measles IgG positive) to enter the room
    • Do not use the room for at least 2 hours after the patient leaves.

See Also

Rashes (Peds)

Source

  • VEP HEALTH ADVISORY 2/25/14